← Evidence library

BIB_447

Initial diagnostic-biopsy MODALITY → Breslow microstaging accuracy / residual tumour at WLE — the MECHANISM behind the TASK24a DT-03 upstage-probability framing + an anti-FCR interpretation + a concrete patient-data item. Distinct from BIB407 (diagnostic accuracy/benign-vs-melanoma discordance), BIB420 (report completeness), BIB421 (timing): this is specifically partial-biopsy → Breslow under-assessment → WLE upstaging, with the reassurance that modality does NOT worsen prognosis. Patient-specific: his diagnostic biopsy was ~Apr 2026 (technique = an open data gap); the 2026-05-26 WLE yield…

Evidence grade

B

Tier

2 (Shellenber

Cited by tasks

22, 24, 24a

Identifiers

PMC7411171

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_447/findings.md (research corpus). This page is a short context summary — not individualised medical advice.